Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

INTRODUCTION: Several lines of evidence suggest that the thyroid hormone signaling pathway is altered in patients with NAFLD and that pharmacological strategies to target the thyroid hormone/thyroid hormone nuclear receptor axis (TH/THR) in the liver may exert beneficial effects. In this study, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Caddeo, Andrea, Serra, Marina, Sedda, Francesca, Bacci, Andrea, Manera, Clementina, Rapposelli, Simona, Columbano, Amedeo, Perra, Andrea, Kowalik, Marta Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996294/
https://www.ncbi.nlm.nih.gov/pubmed/36910628
http://dx.doi.org/10.3389/fonc.2023.1127517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996294/
https://www.ncbi.nlm.nih.gov/pubmed/36910628
http://dx.doi.org/10.3389/fonc.2023.1127517

Ejemplares similares